BROSHY ERAN

Director at INVENTIV HEALTH INC · on record since Jan 19, 2006
Director at NEUROGEN CORP · on record since Mar 16, 2006
Director at UNION STREET ACQUISITION CORP. · on record since Feb 13, 2007
Director at MAGELLAN HEALTH INC · on record since Mar 4, 2009
Director at Certara, Inc. · on record since May 15, 2026
Chairman at Certara, Inc. · on record since May 15, 2026
Director at Theravance Biopharma, Inc. · on record since Jun 12, 2014
CEO at INVENTIV HEALTH INC · on record since Mar 17, 2005

Insider trading activity of BROSHY ERAN

Transactions on record: 189; since Aug 27, 2003

Open-market buys: 4; $905.2K

Open-market sells: 39; $24.6M

Companies traded: 5; last filing May 15, 2026

Figures computed from official regulatory filings — .

Companies where BROSHY ERAN has traded

Certara, Inc.15 tx · $79.1K · May 15, 2026
Theravance Biopharma, Inc.32 tx · $2.9M · Dec 1, 2025
MAGELLAN HEALTH INC14 tx · $571.8K · May 25, 2018
INVENTIV HEALTH INC100 tx · $40.9M · Aug 4, 2010
NEUROGEN CORP28 tx · Dec 17, 2009

Track record of BROSHY ERAN

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of BROSHY ERAN

Co-insiders of BROSHY ERAN

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Certara, Inc.Listing on record	May 15, 2026	ExerciseD (derivative)	-15,757	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Certara, Inc.Listing on record	May 15, 2026	Exercise	15,757	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Certara, Inc.Listing on record	May 15, 2026	AwardD (derivative)	33,222	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Theravance Biopharma, Inc.Listing on record	Dec 1, 2025	Sell	-15,501	20.00 USD	$310K		SEC
Theravance Biopharma, Inc.Listing on record	Dec 1, 2025	Sell	-14,000	20.00 USD	$280K		SEC
Theravance Biopharma, Inc.Listing on record	Dec 1, 2025	ExerciseD (derivative)	14,000	10.15 USD	$142.1K		SEC
Theravance Biopharma, Inc.Listing on record	Nov 14, 2025	ExerciseD (derivative)	14,000	10.15 USD	$142.1K		SEC
Theravance Biopharma, Inc.Listing on record	Nov 14, 2025	Sell	-15,500	18.50 USD	$286.8K		SEC
Theravance Biopharma, Inc.Listing on record	Nov 14, 2025	Sell	-14,000	18.50 USD	$259K		SEC
Theravance Biopharma, Inc.Listing on record	Nov 14, 2025	Sell	-15,500	17.00 USD	$263.5K		SEC
Theravance Biopharma, Inc.Listing on record	Nov 13, 2025	Sell	-15,500	17.00 USD	$263.5K		SEC
Theravance Biopharma, Inc.Listing on record	Nov 13, 2025	Sell	-29,500	18.50 USD	$545.8K		SEC
Theravance Biopharma, Inc.Listing on record	Nov 13, 2025	ExerciseD (derivative)	14,000	10.15 USD	$142.1K		SEC
Theravance Biopharma, Inc.Listing on record	Nov 13, 2025	Sell	-14,000	18.50 USD	$259K		SEC
Certara, Inc.Listing on record	May 22, 2025	Exercise	11,928	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Certara, Inc.Listing on record	May 22, 2025	ExerciseD (derivative)	-11,928	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Certara, Inc.Listing on record	May 22, 2025	AwardD (derivative)	15,757	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Theravance Biopharma, Inc.Listing on record	May 21, 2025	Award	10,649	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Theravance Biopharma, Inc.Listing on record	May 21, 2025	AwardD (derivative)	24,258	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Certara, Inc.Listing on record	May 23, 2024	Exercise	8,663	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Certara, Inc.Listing on record	May 23, 2024	AwardD (derivative)	11,928	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Certara, Inc.Listing on record	May 23, 2024	ExerciseD (derivative)	-8,663	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Theravance Biopharma, Inc.Listing on record	May 10, 2024	Award	10,537	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Theravance Biopharma, Inc.Listing on record	May 10, 2024	AwardD (derivative)	23,576	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Certara, Inc.Listing on record	Aug 23, 2023	Buy	193	16.10 USD	$3.1K	conv 43First in 12mo	SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Certara, Inc.Listing on record	May 15, 2026	ExerciseD (derivative)	-15,757	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Certara, Inc.Listing on record	May 15, 2026	Exercise	15,757	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Certara, Inc.Listing on record	May 15, 2026	AwardD (derivative)	33,222	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Theravance Biopharma, Inc.Listing on record	Dec 1, 2025	Sell	-15,501	20.00 USD	$310K		SEC
Theravance Biopharma, Inc.Listing on record	Dec 1, 2025	Sell	-14,000	20.00 USD	$280K		SEC
Theravance Biopharma, Inc.Listing on record	Dec 1, 2025	ExerciseD (derivative)	14,000	10.15 USD	$142.1K		SEC
Theravance Biopharma, Inc.Listing on record	Nov 14, 2025	ExerciseD (derivative)	14,000	10.15 USD	$142.1K		SEC
Theravance Biopharma, Inc.Listing on record	Nov 14, 2025	Sell	-15,500	18.50 USD	$286.8K		SEC
Theravance Biopharma, Inc.Listing on record	Nov 14, 2025	Sell	-14,000	18.50 USD	$259K		SEC
Theravance Biopharma, Inc.Listing on record	Nov 14, 2025	Sell	-15,500	17.00 USD	$263.5K		SEC
Theravance Biopharma, Inc.Listing on record	Nov 13, 2025	Sell	-15,500	17.00 USD	$263.5K		SEC
Theravance Biopharma, Inc.Listing on record	Nov 13, 2025	Sell	-29,500	18.50 USD	$545.8K		SEC
Theravance Biopharma, Inc.Listing on record	Nov 13, 2025	ExerciseD (derivative)	14,000	10.15 USD	$142.1K		SEC
Theravance Biopharma, Inc.Listing on record	Nov 13, 2025	Sell	-14,000	18.50 USD	$259K		SEC
Certara, Inc.Listing on record	May 22, 2025	Exercise	11,928	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Certara, Inc.Listing on record	May 22, 2025	ExerciseD (derivative)	-11,928	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Certara, Inc.Listing on record	May 22, 2025	AwardD (derivative)	15,757	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Theravance Biopharma, Inc.Listing on record	May 21, 2025	Award	10,649	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Theravance Biopharma, Inc.Listing on record	May 21, 2025	AwardD (derivative)	24,258	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Certara, Inc.Listing on record	May 23, 2024	Exercise	8,663	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Certara, Inc.Listing on record	May 23, 2024	AwardD (derivative)	11,928	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Certara, Inc.Listing on record	May 23, 2024	ExerciseD (derivative)	-8,663	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Theravance Biopharma, Inc.Listing on record	May 10, 2024	Award	10,537	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Theravance Biopharma, Inc.Listing on record	May 10, 2024	AwardD (derivative)	23,576	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Certara, Inc.Listing on record	Aug 23, 2023	Buy	193	16.10 USD	$3.1K	conv 43First in 12mo	SEC